AnaptysBio Inc - Company Profile
Powered by
All the data and insights you need on AnaptysBio Inc in one report.
- Save hours of research time and resources with
our up-to-date AnaptysBio Inc Strategy Report
- Understand AnaptysBio Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
AnaptysBio Inc (AnaptysBio) is a clinical-stage biotechnology company that focuses on the development of antibody candidates for the treatment of atopic dermatitis, ovarian cancer, lung cancer, asthma, psoriasis, inflammation and other autoimmune indications. The company develops its product candidates through its proprietary antibody discovery technology platform that is based on somatic hypermutation (SHM). The company has various product candidates under development for the treatment of moderate-to-severe adult atopic dermatitis, asthma, generalized pustular psoriasis and palmo-plantar pustular psoriasis, and human autoimmune diseases. The company has partnership with GlaxoSmithKline and Bristol-Myers Squibb to develop its product candidates. AnaptysBio is headquartered in San Diego, California, the US.
AnaptysBio Inc premium industry data and analytics
Products and Services
Products |
---|
Pipeline |
Rosnilimab: Inflammatory Diseases |
Imsidolimab: |
XYZ |
XYZ |
XYZ |
Competitor Comparison
Key Parameters | AnaptysBio Inc | F. Hoffmann-La Roche Ltd | AbbVie Inc | Sanofi | Novartis AG |
---|---|---|---|---|---|
Headquarters | United States of America | Switzerland | United States of America | France | Switzerland |
City | San Diego | Basel | North Chicago | Paris | Basel |
State/Province | California | - | Illinois | Ile-de-France | - |
No. of Employees | 117 | 103,605 | 50,000 | 87,994 | 76,057 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
John Orwin | Chairman | Executive Board | 2024 | - |
Daniel Faga | Chief Executive Officer; Director; President - Interim | Executive Board | 2022 | 43 |
Dennis Mulroy | Chief Financial Officer | Senior Management | 2020 | 68 |
Eric Loumeau | Chief Legal Officer | Senior Management | - | 60 |
Paul F. Lizzul, M.D., Ph.D | Chief Medical Officer | Senior Management | 2020 | 48 |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward